Purpose. Peterborough has one of the highest rates of tuberculosis (TB) in the east of England. We reviewed the epidemiology, management and outcome of all cases of bone and joint TB (BJTB) diagnosed since 2000.
INTRODUCTION
Mycobacterium tuberculosis is the most common cause of bone and joint tuberculosis (BJTB) worldwide [1] . Nontuberculous mycobacteria (NTM) can also cause chronic bone and joint infection.
In the UK, a large proportion of BJTB cases are diagnosed in non-UK born individuals. The numbers have increased in recent decades [2] [3] [4] [5] [6] [7] . Whilst the numbers are small, cases of spinal tuberculosis (TB) rose by 84.8 % between 1999 and 2006 in England and Wales [8] .
Peterborough has one of the highest rates of TB in eastern England: the incidence of active TB in 2014 was 28.7 per 100 000 population compared with 6.3 per 100 000 in eastern England as a whole and 12.0 per 100 000 in England overall [9] . Approximately 40 % of the TB treated in Peterborough is extra-pulmonary, such as abdominal TB, which is predominantly seen in the Asian community [10] . We recently noted an increase in cases of diagnosed BJTB, from a background figure of one or two cases per year, and so sought to review the epidemiology, management and outcome of all cases of BJTB diagnosed in our population since 2000.
METHODS Setting
Peterborough and Stamford Hospitals NHS Foundation Trust (PSH) is a district hospital with 600 beds serving a population of approximately 450 000 people in Cambridgeshire, England.
Study design and patients
All adults aged !18 years diagnosed and notified between 1 January 2000 and 31 December 2015 in PSH were retrospectively evaluated with regard to their presentation, medical history, risk factors, management and outcome. Patients were identified from microbiology, histopathology, coding and clinical reports.
Variables
Demographic data and clinical information, including medical history, mode of presentation, physical findings, laboratory, treatment and outcomes were reviewed from medical notes. Upon completion of therapy, patients were followed up for up to 12-24 months.
Definitions BJTB was defined as infection of the skeletal system and associated soft tissue caused by M. tuberculosis. Diagnosis of BJTB was made based on the presenting clinical features and one of the following criteria: (i) positive culture of M. tuberculosis from muscle/synovial tissue or joint fluid; (ii) histopathological demonstration of TB; and (iii) possible BJTB [interferon gamma release assay (IGRA) positive reactivity/previous TB/history of TB exposure/other site positive for TB].
Microbiology
Samples received in microbiology underwent a fluorescent auramine stain to detect acid-fast bacilli (AFB) and were cultured using solid culture techniques [Lowenstein-Jensen medium (Media for Mycobacteria Ltd, Penarth, UK)] until June 2011, when a liquid culture technique (BactecTM MGIT 960 system; Beckton and Dickinson, Oxford, UK) was introduced. Samples were incubated for up to 12 weeks. Identification and susceptibility testing was performed at the Public Health England (PHE) Mycobacterium Reference Laboratory (MRL; London) throughout the study. Molecular methods (e.g. PCR) were not routinely employed during the study period. The PCR test available during the study period was not validated for use for non-respiratory samples.
Statistical analysis
All statistical analysis was conducted using SPSS (IBM, Armonk, USA). A t-test was used to determine statistical significance for continuous data.
Patient care
All patients diagnosed with TB in our hospital are managed by a dedicated respiratory physician with an interest in tuberculosis. TB is a notifiable disease and data regarding diagnosis, anatomical site, ethnicity, treatment, drug resistance and outcome are recorded prospectively wherever possible.
Approval for the study was sought and obtained from the Trust audit committee and categorized as surveillance. Patient management was not affected by the study and all data were held in an anonymous format.
RESULTS

Demographics
Twenty-one patients were identified in the study period. Thirteen patients (62 %) were male with a median age of 35 years (range 20-83 years). Seven patients (33 %) were UK born; five were !60 years and Caucasian. The countries of origin for the 14 (67 %) non-UK-born patients included Pakistan (7), India (3), Bangladesh (1), Liberia (1), Nigeria (1) and Turkey (1) . Four (19 %) cases were diagnosed in people who had moved to the UK 1 to 5 years prior to diagnosis, four (19 %) were diagnosed in people who had moved to the UK between 5 and 10 years prior to diagnosis and three (14 %) were diagnosed in people who had been present in the UK for >10 years. There was no information about the year of entry to the UK for three ( (Fig. 1) . As a comparison with other sites of TB, there were 3 cases of BJTB in 2014 versus 24 cases of pulmonary TB and 21 cases of non-pulmonary TB.
Clinical features
The most frequent presenting complaint was localized pain (16; 76 %) followed by fever (11; 53 %), weight loss (10; 48 %) and swelling (7; 33 %). Five had neurological symptoms (24 %). Symptom duration prior to diagnosis ranged from 2 weeks to 2 years (median 4 months; IQR 3-9 months). Neurological symptoms did not occur in patients with symptoms of less than 3 months (Table 1) .
TB exposure
Three patients (14 %) had previously been treated for TB; one case each of pulmonary disease, renal disease and cervical lymphadenitis.
Anatomical site
Thirteen (62 %) had spinal disease, six (29 %) had involvement of the lower limb and three (14 %) had involvement of the upper limb. One patient (5 %) had TB in both the foot and thumb. Nine (43 %) patients had involvement of another site with TB (Table 2) .
Co-morbidities
One patient had diabetes mellitus and one was receiving cortisone replacement for Addison's disease. Routine testing for human immunodeficiency virus (HIV) and hepatitis B and C was only undertaken systematically from 2010 onwards. All 20 patients tested for HIV were seronegative. No case of co-infection with hepatitis C was identified in this cohort. The single case of positive hepatitis B serology revealed a previous cleared infection with natural immunity.
Radiology and diagnostic procedures
The most frequently used forms of imaging were computed tomography (CT) (10; 48 %), magnetic resonance imaging (MRI) (9; 43 %) and plain imaging (2; 10 %). No data were available for two patients. Debridement and/or excision biopsies were performed for eight (38 %) patients and CTguided biopsy was used for seven (33 %) patients. Four patients had a sample taken from another site [two lymph nodes; one bronchial lavage (BAL); one pleural biopsy]. No sample was sent for two patients.
Histopathology
Seven (33 %) patients had a bone biopsy sent for histology. Three samples were normal but two showed caseation (highly suggestive of TB) and two showed granulomas (suggestive of TB). Of the four patients in whom another site was biopsied, three had a sample sent to histology (two lymph node biopsies, each demonstrating either granulomatous inflammation or caseation, and one pleural biopsy that was reported as fibrotic reactive changes with no features suggestive of TB).
Microbiology
Fourteen (67 %) patients had a bone biopsy or aspirate sent to microbiology. No samples were smear-positive, but 11 were culture-positive (52 % of the total; 76 % of those with a sample submitted for culture). Four further patients had a sample from another site (two lymph nodes; one BAL; one pleural biopsy). One of the lymph node biopsies (granulomatous inflammation) and the BAL were positive, so overall, TB was cultured in 13/18 (72 %) samples received in microbiology (48 % of the total cohort). Eleven cases (77 %) were fully susceptible to first-line anti-tuberculous therapy (ATT); one (8 %) patient had an isoniazid-resistant isolate and one patient had a pyrazinamide-resistant isolate. In both resistant cases, the patients were non-UK born. No multidrug-resistant (MDR) strains were identified.
Medical interventions
Nineteen of the 21 patients (90 %) received ATT. One patient died before treatment commencement, and one patient with a non-healing digital thorn injury (index finger) refused therapy. All 19 patients received quadruple therapy with rifampicin (R), isoniazid (H), pyrazinamide (Z) and ethambutol (E) until sensitivities were available. Of the 17 patients who received treatment for fully sensitive TB, 9 received standard therapy with 2 months of RHZE followed by 4 months of RH. The commonest reasons for increased duration of therapy in this group were pyrazinamide intolerance (three received 2 months of RHE and then 7 months of RH) and central nervous system involvement (two received 2 months of RHZE and then 10 months of RH and prednisolone). Previous TB treatment increased the duration of standard therapy to 9 months in two patients who also received moxifloxacin (M) for the initial phase (2 months of RHZME followed by 7 months of RHE) and 12 months in another who was intolerant of moxifloxacin (who received 2 months of RHZE and then 10 months of RHE). There is little information about the case with isoniazid resistance, other than that the patient received 16 months of therapy in total. The patient with pyrazinamide resistance received 2 months of RHE and then 7 months of RH. ATT was tolerated without untoward drug side-effects in most cases. Pyrazinamide intolerance with erythematous rash/arthralgia limited its use in three patients. One patient developed thyroid goitre whilst taking therapy but remained euthyroid. Two patients developed isoniazid-induced peripheral neuropathy that responded to high-dose pyridoxine. No patient required treatment to be stopped due to liver inflammation.
Surgical interventions
Two patients required spinal stabilization and one patient underwent decompressive laminectomy at the time of diagnosis.
Markers of therapy response:
Improvement in haemoglobin, erythrocyte sedimentation rate (ESR) and serum albumin levels are useful biological markers of ATT compliance and disease regression. Outcome and mortality One patient with miliary TB, meningitis and spinal involvement died prior to commencing therapy. The patient with the digital thorn injury (index finger) who refused therapy was followed up for 12 months and to date has not Since completing treatment, four patients have been rereferred to the TB team for investigation. The patient with TB paronychia (middle finger) has subsequently been diagnosed with a chronic and relapsing pulmonary infection caused by a NTM in the setting of bronchiectasis and systemic sclerosis. A further patient's symptoms recurred and he underwent repeat incision and drainage of a tibial collection; TB infection was not identified, and he improved with surgical treatment.
DISCUSSION
This study highlights that men are more likely to be affected with BJTB, which has been found previously [11] . The average age of BJTB patients is 43 years, which reflects the average age for TB across eastern England. Due to the relatively young age of TB patients in this study, it is not surprising that the rate of co-morbidities is low. The reason for an increased male preponderance for BJTB is not clear. It may be that migrants are more likely to be male, live and work in poor conditions and travel to and from countries with increased incidence of TB. Thus, this gender difference may become less apparent in the future as men and women have equivalent opportunities to migrate, work and travel. Unfortunately, we did not record travel to endemic countries or contact with other people from endemic countries since arrival in the UK. Alternatively, differences in host genetic susceptibility, as has been found in recent genetic studies [12, 13] , and their interaction with bacterial genotype [14, 15] could be responsible for the risk of extra-pulmonary TB in this population.
UK national patients had a median age of 65 (range 63-91), in contrast to non-UK nationals, whose median age was 28 (range 20-44). All patients over the age of 60 with BJTB were UK-born and Caucasian. This may suggest that BJTB in Caucasians is a reactivation event and a consequence of waning immunity, such as occurs with ageing. Certainly, in our limited experience, other co-morbidities (diabetes, renal impairment and HIV) were not overly represented in the older Caucasians.
There is a trend of increasing numbers of BJTB infections over time. This may reflect increasing awareness of BJTB and increased likelihood that TB will be considered in the differential diagnosis. The resurgence of TB incidence in developed countries has been attributed to a rise in migration from countries where TB is highly prevalent; immunosuppression; the emergence of MDR strains of M. tuberculosis; and an increasingly ageing population [16] . In this study, we found that migration was the most likely explanation for BJTB. None of our patients with BJTB had a diagnosis of HIV or immunosuppression from any cause. The majority of patients with BJTB were non-UK born (67 %) and were likely to have originated from Pakistan and India in particular, reflecting our catchment area's diverse ethnicity. This migrant population is at increased risk of extra-pulmonary TB and several explanations have been postulated for this [8, 17] . For instance, extra-pulmonary disease may be more likely to reflect the reactivation of disease initially acquired while in a TB-endemic country, in contrast to pulmonary disease, which is more likely to represent 'new' infection. The World Health Organization publishes rates of TB incidence by country and this document should be referred to in the assessment of risk of TB likelihood [18] .
The term BJTB emphasizes the involvement of any or multiple parts of the musculoskeletal system. As in other case series of BJTB, TB appears to have a predilection for the spine, accounting for about half of all cases in this study [11, 19] . The most common presenting complaint was that of localized pain (76 %) and this lasted from 2 weeks to 18 months, with no neurological symptoms being reported before 3 months. Patients appeared to 'tolerate' pain but not neurological symptoms.
The difficulties and delays in diagnosing BJTB are well recognized [20, 21] and the association of trauma (as a cause for the pain) often hinders appropriate investigation; the risk of TB is commonly underestimated without Table 3 . Learning points A high index of clinical suspicion for BJTB diagnosis is required at all times. TB should be considered in any patient who presents with unexplained pain, fever and weight loss and especially when another cause is not immediately apparent. These should be considered to be red flag symptoms. It is important to ascertain whether patients were born in a country where TB is endemic. TB often presents within a few years of migration. It is estimated that one-third of the world's population is infected with TB and therefore disease may be caused by the reactivation of latent TB. However, reinfection following foreign travel should always be considered. The diagnosis of BJTB is proven by diagnostic aspiration/biopsy and this should be undertaken as soon as possible. It is important to keep in mind that TB should be considered in the clinical setting of atypical osteoarticular disease or where there is inadequate response to treatment. Appropriate samples must be sent to microbiology for AFB and mycobacterial culture. Biochemical and cytological analysis of joint aspirate may suggest a diagnosis of TB that may be confirmed later by mycobacterial culture. Microscopy for AFB of any aspirate fluid and pus is often negative (i.e. low sensitivity). NAAT and culture can be misleading, as the sensitivity is not 100 %. The clinical picture is crucial. A multidisciplinary approach involving the local TB lead (respiratory or infectious diseases physician), the clinical microbiology laboratory and orthopaedic/ neurosurgical colleagues is essential. Therapy is prolonged and close review essential as complications with ATT (e.g. hepatitis, malabsorption and drug interactions) are not infrequent. HIV must always be considered. The annual incidence of TB in HIV infection is 10 %.
consideration of the prevalence of TB in the country of the person's birth; the presence of any concurrent pulmonary involvement need not be present and thus diagnosis will usually require a surgical biopsy or joint aspiration as compared to the relative ease of the spontaneously induced sputum samples that are used to investigate pulmonary TB. Diagnostic delay may result in further skeletal damage and possible resultant compression and paralysis [22] . As half of patients either had fevers (53 %) or weight loss (48 %), these 'red flag' symptoms should continue to identify patients with inflammatory arthropathy who require further evaluation and investigation.
Culture, typically taken from the most accessible site, was a sensitive investigation to detect BJTB; 76 % of patients whose sample was submitted for culture grew M. tuberculosis. Histology was a useful confirmatory addition for those who had a positive culture for TB, but two patients with BJTB had entirely normal histology. This underlines how important microbiology cultures from suspected TB sites are, particularly in an era of increasing resistance.
Under-reporting of TB in the UK is well described. Sheldon and colleagues indicated that just over half of all TB diagnosed in the UK is notified [19, 23] . This represents a substantial potential public health risk and there is an urgent need for the current issues to be addressed. We present some important learning points in Table 3 .
Overall, the TB treatment outcomes were satisfactory in our study and most persons completed a course of ATT. The symptoms resolved completely in 45 % of patients and, to date, no recurrences have been noted. One patient died prior to starting therapy and one patient is wheelchairbound due to erosive spinal degeneration.
The limitations of the study include its single-centre retrospective design; we also did not routinely collect data on BCG vaccination status. Although vaccination is not considered to be protective, it may have been interesting to see know whether this cohort of extra-pulmonary MTB had been vaccinated. BJTB diagnosis remains a challenge and requires a very high index of suspicion. Prompt diagnosis and treatment is essential to prevent serious irreversible damage and neurological compromise. Management should always be multidisciplinary and involve the respiratory physicians, orthopaedic surgeons, pathologists (histopathology and microbiology), TB specialist nurses and TB pharmacists, amongst others.
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